ADMA News and Press, ADMA Biologics Inc From 05/07/20

Image source: The Motley Fool. ADMA Biologics Inc   (NASDAQ: ADMA) Q1 2020 Earnings Call May 6, 2020 , 4:30 p.m. ET Operator Continue reading

MicroVision (NASDAQ: MVIS ) -24% . More news on: MicroVision, Inc., Vista Outdoor Inc., SG Blocks, Inc., Stocks on the move, , Read more ...

OSAKA, Japan , and KING OF PRUSSIA, Pa. , May 7, 2020 /PRNewswire/ -- The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the development of a plasma-derived hyperimmune globulin therapy for COVID-19, is rapidly building...

RAMSEY, N.J. and BOCA RATON, Fla., May 07, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of imm...

Start Time: 16:30 End Time: 17:13 ADMA Biologics, Inc. (ADMA) Q1 2020 Earnings Conference Call May 06, 2020, 16:30 PM ET Company Participants Adam Grossman - Founder, President and CEO Brian Lenz - EVP and CFO Samuel Martin - Argot Partners Conference Call Participants ...

Gainers: TTPH   +64.75% .   TWLO   +24.6% . FSLY   +21.9% . TPC   +17.1% . LYFT   +15.5% . More news on: Tetraphase Pharmaceuticals, Inc., Twilio Inc., Fastly, Inc., Stocks on the move, , Read more ...

ADMA Biologics (NASDAQ: ADMA ): Q1 GAAP EPS of -$0.26 misses by $0.15 . More news on: ADMA Biologics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Achieved First Quarter 2020 Total Revenues of $10.2 Million, a 189% Increase Over First Quarter 2019 Strengthened Balance Sheet Through Successful Completion of Underwritten Public Offering Management to Host Conference Call and Webcast Today at 4:30 p.m. ET RAMSEY, N.J. and B...

RAMSEY, N.J. and BOCA RATON, Fla., April 29, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of i...

ADMA Biologics ( ADMA ) is a commercial stage biopharma company that has shown strong sales growth of late and is in a market segment that should also see significant growth over the next few years. Like so many other small-cap biopharma stocks, ADMA has seen its shares plummet during the COVI...